Literature DB >> 18055545

Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.

Micha M M Wilhelmus1, Irene Otte-Höller, Jos J J van Triel, Robert Veerhuis, Marion L C Maat-Schieman, Guojun Bu, Robert M W de Waal, Marcel M Verbeek.   

Abstract

Inefficient clearance of A beta, caused by impaired blood-brain barrier crossing into the circulation, seems to be a major cause of A beta accumulation in the brain of late-onset Alzheimer's disease patients and hereditary cerebral hemorrhage with amyloidosis Dutch type. We observed association of receptor for advanced glycation end products, CD36, and low-density lipoprotein receptor (LDLR) with cerebral amyloid angiopathy in both Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis Dutch type brains and increased low-density lipoprotein receptor-related protein-1 (LRP-1) expression by perivascular cells in cerebral amyloid angiopathy. We investigated if these A beta receptors are involved in A beta internalization and in A beta-mediated cell death of human cerebrovascular cells and astrocytes. Expression of both the LRP-1 and LDLR by human brain pericytes and leptomeningeal smooth muscle cells, but not by astrocytes, increased on incubation with A beta. Receptor-associated protein specifically inhibited A beta-mediated up-regulation of LRP-1, but not of LDLR, and receptor-associated protein also decreased A beta internalization and A beta-mediated cell death. We conclude that especially LRP-1 and, to a minor extent, LDLR are involved in A beta internalization by and A beta-mediated cell death of cerebral perivascular cells. Although perivascular cells may adapt their A beta internalization capacity to the levels of A beta present, saturated LRP-1/LDLR-mediated uptake of A beta results in degeneration of perivascular cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055545      PMCID: PMC2111121          DOI: 10.2353/ajpath.2007.070050

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.

Authors:  Micha M M Wilhelmus; Wilbert C Boelens; Irene Otte-Höller; Bram Kamps; Robert M W de Waal; Marcel M Verbeek
Journal:  Brain Res       Date:  2006-04-24       Impact factor: 3.252

Review 2.  Neurovascular mechanisms of Alzheimer's neurodegeneration.

Authors:  Berislav V Zlokovic
Journal:  Trends Neurosci       Date:  2005-04       Impact factor: 13.837

Review 3.  LRP in amyloid-beta production and metabolism.

Authors:  Guojun Bu; Judy Cam; Celina Zerbinatti
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

4.  beta-Amyloid efflux mediated by p-glycoprotein.

Authors:  F C Lam; R Liu; P Lu; A B Shapiro; J M Renoir; F J Sharom; P B Reiner
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

5.  Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains.

Authors:  M M M Wilhelmus; I Otte-Höller; P Wesseling; R M W de Waal; W C Boelens; M M Verbeek
Journal:  Neuropathol Appl Neurobiol       Date:  2006-04       Impact factor: 8.090

6.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

Authors:  D E Kang; C U Pietrzik; L Baum; N Chevallier; D E Merriam; M Z Kounnas; S L Wagner; J C Troncoso; C H Kawas; R Katzman; E H Koo
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

7.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

Authors:  M Shibata; S Yamada; S R Kumar; M Calero; J Bading; B Frangione; D M Holtzman; C A Miller; D K Strickland; J Ghiso; B V Zlokovic
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.

Authors:  A Lorenzo; M Yuan; Z Zhang; P A Paganetti; C Sturchler-Pierrat; M Staufenbiel; J Mautino; F S Vigo; B Sommer; B A Yankner
Journal:  Nat Neurosci       Date:  2000-05       Impact factor: 24.884

9.  Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice.

Authors:  Dongfeng Cao; Ken-ichiro Fukuchi; Hongquan Wan; Helen Kim; Ling Li
Journal:  Neurobiol Aging       Date:  2005-10-19       Impact factor: 4.673

10.  Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.

Authors:  Y Le; W Gong; H L Tiffany; A Tumanov; S Nedospasov; W Shen; N M Dunlop; J L Gao; P M Murphy; J J Oppenheim; J M Wang
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

View more
  55 in total

1.  The expression of LDL receptor in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.

Authors:  Masaki Ueno; Bin Wu; Toshitaka Nakagawa; Yukiko Nagai; Masayuki Onodera; Cheng-Long Huang; Takashi Kusaka; Kenji Kanenishi; Haruhiko Sakamoto
Journal:  Histochem Cell Biol       Date:  2010-05-11       Impact factor: 4.304

2.  High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.

Authors:  Hisham Qosa; Loqman A Mohamed; Sweilem B Al Rihani; Yazan S Batarseh; Quoc-Viet Duong; Jeffrey N Keller; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

3.  Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Authors:  Robert D Bell; Ethan A Winkler; Abhay P Sagare; Itender Singh; Barb LaRue; Rashid Deane; Berislav V Zlokovic
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 4.  Pericyte Plasticity in the Brain.

Authors:  Gabryella S P Santos; Luiz A V Magno; Marco A Romano-Silva; Akiva Mintz; Alexander Birbrair
Journal:  Neurosci Bull       Date:  2018-10-26       Impact factor: 5.203

5.  Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.

Authors:  Shravan K Chintala
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

6.  Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.

Authors:  Laibaik Park; Kenzo Koizumi; Sleiman El Jamal; Ping Zhou; Mary Lou Previti; William E Van Nostrand; George Carlson; Costantino Iadecola
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

Review 7.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

8.  Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease.

Authors:  Nicola B Hamilton; David Attwell; Catherine N Hall
Journal:  Front Neuroenergetics       Date:  2010-05-21

9.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

10.  LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.

Authors:  Takahisa Kanekiyo; Chia-Chen Liu; Mitsuru Shinohara; Jie Li; Guojun Bu
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.